UnitedHealth Group (UNH) is back in focus after its latest earnings report showed revenue and guidance below expectations, as higher medical costs and a weaker Medicare Advantage outlook weighed on investor sentiment.

Those Medicare Advantage concerns and rising medical costs have been reflected in the share price, with a 30 day share price return of 12.47% and a 1 year total shareholder return of 42.62% decline, while the recent 7 day share price return of 5.98% hints at a short term rebound attempt.

If this volatility has you looking beyond large managed care names, it may be an opportunity to scan 25 healthcare AI stocks for ideas at the intersection of healthcare and technology.

So with UnitedHealth now trading well below recent analyst targets and screens flagging a wide intrinsic discount, is the recent selloff creating a mispriced entry point, or is the market already baking in weaker future growth?

Most Popular Narrative: 39.8% Undervalued

UnitedHealth Group's narrative fair value of $486.86 sits well above the last close at $293.19, which is what has some investors paying close attention to this valuation gap.

UNH’s revenue growth stems from serving more people and providing comprehensive healthcare solutions across its offerings. Double digit growth at both Optum and UnitedHealthcare has contributed to the company’s financial success.

For investors curious how this narrative arrives at a fair value near $500, the core thesis centers on steady premium expansion, resilient margins, and a richer mix of higher value Optum services. To understand how those assumptions are modeled over the next decade, the full narrative details the earnings path used to support that valuation.

Result: Fair Value of $486.86 (UNDERVALUED)

However, this hinges on regulatory stability and on competitive pressure not eroding margins, with legal or policy shifts around Medicare, Medicaid, or drug pricing serving as clear swing factors.

Build Your Own UnitedHealth Group Narrative

If you look at the numbers and reach a different conclusion, or simply prefer to base decisions on your own research, you can build a custom view in just a few minutes using Do it your way.

A great starting point for your UnitedHealth Group research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If you are weighing what to do with UnitedHealth, this is the moment to widen your watchlist and let high quality filters point you toward fresh opportunities.

• Target quality at a discount by checking stocks our screener flags as 53 high quality undervalued stocks, where solid fundamentals meet prices that may not fully reflect them.
• Secure potential income streams by reviewing companies in our 13 dividend fortresses that focus on higher yielding payouts with a focus on resilience.
• Protect your downside by scanning the 85 resilient stocks with low risk scores that highlights businesses with more resilient risk profiles and steadier financial footing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.